We investigated the genetic influence on diabetes progression by constructing a genetic risk score ( GRS ) of all @ validated type @ diabetes susceptibility variants , a GRS of @ variants linked to - cell function and a GRS of @ variants linked to insulin sensitivity and assessed the association between number of risk alleles and time from diagnosis until first redeemed prescription of either any glucose lowering drug or an insulin drug .